Treating hypoxemic patients with SARS-COV-2 pneumonia: Back to applied physiology

Anaesth Crit Care Pain Med. 2020 Jun;39(3):389-390. doi: 10.1016/j.accpm.2020.04.003. Epub 2020 Apr 16.

Authors

Karim Bendjelid¹, Giraud Raphaël²

Affiliations

¹ Intensive care division, university hospitals, Geneva, Switzerland; Geneva haemodynamic research group, Geneva, Switzerland; Faculty of medicine, Geneva, Switzerland. Electronic address: karim.bendjelid@hcuge.ch.
² Intensive care division, university hospitals, Geneva, Switzerland; Geneva haemodynamic research group, Geneva, Switzerland; Faculty of medicine, Geneva, Switzerland.

No abstract available

Keywords: Hypoxemia; SARS-CoV-2 pneumonia; Shunt; Venous admixture.

Publication types

Letter

MeSH terms

Almitrine / pharmacology
Almitrine / supply & distribution
Betacoronavirus*
COVID-19
Capillary Leak Syndrome / etiology
Capillary Leak Syndrome / physiopathology
Coronavirus Infections / complications
Coronavirus Infections / diagnostic imaging
Coronavirus Infections / physiopathology*
Coronavirus Infections / therapy
Humans
Hypoxia / etiology
Hypoxia / mortality
Hypoxia / physiopathology*
Hypoxia / therapy
Lung / diagnostic imaging
Lung Compliance
Pandemics
Patient Positioning
Pneumonia, Viral / complications
Pneumonia, Viral / diagnostic imaging
Pneumonia, Viral / physiopathology*
Pneumonia, Viral / therapy
Positive-Pressure Respiration*
Pulmonary Circulation*
Pulmonary Edema / etiology
Pulmonary Edema / physiopathology
Respiratory Mechanics*
SARS-CoV-2
Switzerland
Tomography, X-Ray Computed
Vasoconstriction / drug effects
Vasoconstrictor Agents / pharmacology
Vasoconstrictor Agents / supply & distribution

Substances

Vasoconstrictor Agents
Almitrine